Chapter 1 Industry Overview

1.1 Definition

1.2 Assumptions

1.3 Research Scope

1.4 Market Analysis by Regions

1.4.1 North America Market States and Outlook (2022-2027)

1.4.2 East Asia Market States and Outlook (2022-2027)

1.4.3 Europe Market States and Outlook (2022-2027)

1.4.4 South Asia Market States and Outlook (2022-2027)

1.4.5 Southeast Asia Market States and Outlook (2022-2027)

1.4.6 Middle East Market States and Outlook (2022-2027)

1.4.7 Africa Market States and Outlook (2022-2027)

1.4.8 Oceania Market States and Outlook (2022-2027)

1.4.9 South America Market States and Outlook (2022-2027)

1.5 Global Opioids Drug Market Size Analysis from 2022 to 2027

1.5.1 Global Opioids Drug Market Size Analysis from 2022 to 2027 by Consumption Volume

1.5.2 Global Opioids Drug Market Size Analysis from 2022 to 2027 by Value

1.5.3 Global Opioids Drug Price Trends Analysis from 2022 to 2027

1.6 COVID-19 Outbreak: Opioids Drug Industry Impact

Chapter 2 Global Opioids Drug Competition by Types, Applications, and Top Regions and Countries

2.1 Global Opioids Drug (Volume and Value) by Type

2.1.1 Global Opioids Drug Consumption and Market Share by Type (2016-2021)

2.1.2 Global Opioids Drug Revenue and Market Share by Type (2016-2021)

2.2 Global Opioids Drug (Volume and Value) by Application

2.2.1 Global Opioids Drug Consumption and Market Share by Application (2016-2021)

2.2.2 Global Opioids Drug Revenue and Market Share by Application (2016-2021)

2.3 Global Opioids Drug (Volume and Value) by Regions

2.3.1 Global Opioids Drug Consumption and Market Share by Regions (2016-2021)

2.3.2 Global Opioids Drug Revenue and Market Share by Regions (2016-2021)

Chapter 3 Production Market Analysis

3.1 Global Production Market Analysis

3.1.1 2016-2021 Global Capacity, Production, Capacity Utilization Rate, Ex-Factory Price, Revenue, Cost, Gross and Gross Margin Analysis

3.1.2 2016-2021 Major Manufacturers Performance and Market Share

3.2 Regional Production Market Analysis

3.2.1 2016-2021 Regional Market Performance and Market Share

3.2.2 North America Market

3.2.3 East Asia Market

3.2.4 Europe Market

3.2.5 South Asia Market

3.2.6 Southeast Asia Market

3.2.7 Middle East Market

3.2.8 Africa Market

3.2.9 Oceania Market

3.2.10 South America Market

3.2.11 Rest of the World Market

Chapter 4 Global Opioids Drug Sales, Consumption, Export, Import by Regions (2016-2021)

4.1 Global Opioids Drug Consumption by Regions (2016-2021)

4.2 North America Opioids Drug Sales, Consumption, Export, Import (2016-2021)

4.3 East Asia Opioids Drug Sales, Consumption, Export, Import (2016-2021)

4.4 Europe Opioids Drug Sales, Consumption, Export, Import (2016-2021)

4.5 South Asia Opioids Drug Sales, Consumption, Export, Import (2016-2021)

4.6 Southeast Asia Opioids Drug Sales, Consumption, Export, Import (2016-2021)

4.7 Middle East Opioids Drug Sales, Consumption, Export, Import (2016-2021)

4.8 Africa Opioids Drug Sales, Consumption, Export, Import (2016-2021)

4.9 Oceania Opioids Drug Sales, Consumption, Export, Import (2016-2021)

4.10 South America Opioids Drug Sales, Consumption, Export, Import (2016-2021)

Chapter 5 North America Opioids Drug Market Analysis

5.1 North America Opioids Drug Consumption and Value Analysis

5.1.1 North America Opioids Drug Market Under COVID-19

5.2 North America Opioids Drug Consumption Volume by Types

5.3 North America Opioids Drug Consumption Structure by Application

5.4 North America Opioids Drug Consumption by Top Countries

5.4.1 United States Opioids Drug Consumption Volume from 2016 to 2021

5.4.2 Canada Opioids Drug Consumption Volume from 2016 to 2021

5.4.3 Mexico Opioids Drug Consumption Volume from 2016 to 2021

Chapter 6 East Asia Opioids Drug Market Analysis

6.1 East Asia Opioids Drug Consumption and Value Analysis

6.1.1 East Asia Opioids Drug Market Under COVID-19

6.2 East Asia Opioids Drug Consumption Volume by Types

6.3 East Asia Opioids Drug Consumption Structure by Application

6.4 East Asia Opioids Drug Consumption by Top Countries

6.4.1 China Opioids Drug Consumption Volume from 2016 to 2021

6.4.2 Japan Opioids Drug Consumption Volume from 2016 to 2021

6.4.3 South Korea Opioids Drug Consumption Volume from 2016 to 2021

Chapter 7 Europe Opioids Drug Market Analysis

7.1 Europe Opioids Drug Consumption and Value Analysis

7.1.1 Europe Opioids Drug Market Under COVID-19

7.2 Europe Opioids Drug Consumption Volume by Types

7.3 Europe Opioids Drug Consumption Structure by Application

7.4 Europe Opioids Drug Consumption by Top Countries

7.4.1 Germany Opioids Drug Consumption Volume from 2016 to 2021

7.4.2 UK Opioids Drug Consumption Volume from 2016 to 2021

7.4.3 France Opioids Drug Consumption Volume from 2016 to 2021

7.4.4 Italy Opioids Drug Consumption Volume from 2016 to 2021

7.4.5 Russia Opioids Drug Consumption Volume from 2016 to 2021

7.4.6 Spain Opioids Drug Consumption Volume from 2016 to 2021

7.4.7 Netherlands Opioids Drug Consumption Volume from 2016 to 2021

7.4.8 Switzerland Opioids Drug Consumption Volume from 2016 to 2021

7.4.9 Poland Opioids Drug Consumption Volume from 2016 to 2021

Chapter 8 South Asia Opioids Drug Market Analysis

8.1 South Asia Opioids Drug Consumption and Value Analysis

8.1.1 South Asia Opioids Drug Market Under COVID-19

8.2 South Asia Opioids Drug Consumption Volume by Types

8.3 South Asia Opioids Drug Consumption Structure by Application

8.4 South Asia Opioids Drug Consumption by Top Countries

8.4.1 India Opioids Drug Consumption Volume from 2016 to 2021

8.4.2 Pakistan Opioids Drug Consumption Volume from 2016 to 2021

8.4.3 Bangladesh Opioids Drug Consumption Volume from 2016 to 2021

Chapter 9 Southeast Asia Opioids Drug Market Analysis

9.1 Southeast Asia Opioids Drug Consumption and Value Analysis

9.1.1 Southeast Asia Opioids Drug Market Under COVID-19

9.2 Southeast Asia Opioids Drug Consumption Volume by Types

9.3 Southeast Asia Opioids Drug Consumption Structure by Application

9.4 Southeast Asia Opioids Drug Consumption by Top Countries

9.4.1 Indonesia Opioids Drug Consumption Volume from 2016 to 2021

9.4.2 Thailand Opioids Drug Consumption Volume from 2016 to 2021

9.4.3 Singapore Opioids Drug Consumption Volume from 2016 to 2021

9.4.4 Malaysia Opioids Drug Consumption Volume from 2016 to 2021

9.4.5 Philippines Opioids Drug Consumption Volume from 2016 to 2021

9.4.6 Vietnam Opioids Drug Consumption Volume from 2016 to 2021

9.4.7 Myanmar Opioids Drug Consumption Volume from 2016 to 2021

Chapter 10 Middle East Opioids Drug Market Analysis

10.1 Middle East Opioids Drug Consumption and Value Analysis

10.1.1 Middle East Opioids Drug Market Under COVID-19

10.2 Middle East Opioids Drug Consumption Volume by Types

10.3 Middle East Opioids Drug Consumption Structure by Application

10.4 Middle East Opioids Drug Consumption by Top Countries

10.4.1 Turkey Opioids Drug Consumption Volume from 2016 to 2021

10.4.2 Saudi Arabia Opioids Drug Consumption Volume from 2016 to 2021

10.4.3 Iran Opioids Drug Consumption Volume from 2016 to 2021

10.4.4 United Arab Emirates Opioids Drug Consumption Volume from 2016 to 2021

10.4.5 Israel Opioids Drug Consumption Volume from 2016 to 2021

10.4.6 Iraq Opioids Drug Consumption Volume from 2016 to 2021

10.4.7 Qatar Opioids Drug Consumption Volume from 2016 to 2021

10.4.8 Kuwait Opioids Drug Consumption Volume from 2016 to 2021

10.4.9 Oman Opioids Drug Consumption Volume from 2016 to 2021

Chapter 11 Africa Opioids Drug Market Analysis

11.1 Africa Opioids Drug Consumption and Value Analysis

11.1.1 Africa Opioids Drug Market Under COVID-19

11.2 Africa Opioids Drug Consumption Volume by Types

11.3 Africa Opioids Drug Consumption Structure by Application

11.4 Africa Opioids Drug Consumption by Top Countries

11.4.1 Nigeria Opioids Drug Consumption Volume from 2016 to 2021

11.4.2 South Africa Opioids Drug Consumption Volume from 2016 to 2021

11.4.3 Egypt Opioids Drug Consumption Volume from 2016 to 2021

11.4.4 Algeria Opioids Drug Consumption Volume from 2016 to 2021

11.4.5 Morocco Opioids Drug Consumption Volume from 2016 to 2021

Chapter 12 Oceania Opioids Drug Market Analysis

12.1 Oceania Opioids Drug Consumption and Value Analysis

12.2 Oceania Opioids Drug Consumption Volume by Types

12.3 Oceania Opioids Drug Consumption Structure by Application

12.4 Oceania Opioids Drug Consumption by Top Countries

12.4.1 Australia Opioids Drug Consumption Volume from 2016 to 2021

12.4.2 New Zealand Opioids Drug Consumption Volume from 2016 to 2021

Chapter 13 South America Opioids Drug Market Analysis

13.1 South America Opioids Drug Consumption and Value Analysis

13.1.1 South America Opioids Drug Market Under COVID-19

13.2 South America Opioids Drug Consumption Volume by Types

13.3 South America Opioids Drug Consumption Structure by Application

13.4 South America Opioids Drug Consumption Volume by Major Countries

13.4.1 Brazil Opioids Drug Consumption Volume from 2016 to 2021

13.4.2 Argentina Opioids Drug Consumption Volume from 2016 to 2021

13.4.3 Columbia Opioids Drug Consumption Volume from 2016 to 2021

13.4.4 Chile Opioids Drug Consumption Volume from 2016 to 2021

13.4.5 Venezuela Opioids Drug Consumption Volume from 2016 to 2021

13.4.6 Peru Opioids Drug Consumption Volume from 2016 to 2021

13.4.7 Puerto Rico Opioids Drug Consumption Volume from 2016 to 2021

13.4.8 Ecuador Opioids Drug Consumption Volume from 2016 to 2021

Chapter 14 Company Profiles and Key Figures in Opioids Drug Business

14.1 Teva

14.1.1 Teva Company Profile

14.1.2 Teva Opioids Drug Product Specification

14.1.3 Teva Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.2 Pfizer

14.2.1 Pfizer Company Profile

14.2.2 Pfizer Opioids Drug Product Specification

14.2.3 Pfizer Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.3 Amneal Pharma

14.3.1 Amneal Pharma Company Profile

14.3.2 Amneal Pharma Opioids Drug Product Specification

14.3.3 Amneal Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.4 Purdue Pharma

14.4.1 Purdue Pharma Company Profile

14.4.2 Purdue Pharma Opioids Drug Product Specification

14.4.3 Purdue Pharma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.5 Endo

14.5.1 Endo Company Profile

14.5.2 Endo Opioids Drug Product Specification

14.5.3 Endo Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.6 Mallinckrodt

14.6.1 Mallinckrodt Company Profile

14.6.2 Mallinckrodt Opioids Drug Product Specification

14.6.3 Mallinckrodt Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.7 Mylan

14.7.1 Mylan Company Profile

14.7.2 Mylan Opioids Drug Product Specification

14.7.3 Mylan Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.8 J&J

14.8.1 J&J Company Profile

14.8.2 J&J Opioids Drug Product Specification

14.8.3 J&J Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.9 Collegium

14.9.1 Collegium Company Profile

14.9.2 Collegium Opioids Drug Product Specification

14.9.3 Collegium Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.10 INSYS

14.10.1 INSYS Company Profile

14.10.2 INSYS Opioids Drug Product Specification

14.10.3 INSYS Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.11 Hikma

14.11.1 Hikma Company Profile

14.11.2 Hikma Opioids Drug Product Specification

14.11.3 Hikma Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

14.12 Egalet

14.12.1 Egalet Company Profile

14.12.2 Egalet Opioids Drug Product Specification

14.12.3 Egalet Opioids Drug Production Capacity, Revenue, Price and Gross Margin (2016-2021)

Chapter 15 Global Opioids Drug Market Forecast (2022-2027)

15.1 Global Opioids Drug Consumption Volume, Revenue and Price Forecast (2022-2027)

15.1.1 Global Opioids Drug Consumption Volume and Growth Rate Forecast (2022-2027)

15.1.2 Global Opioids Drug Value and Growth Rate Forecast (2022-2027)

15.2 Global Opioids Drug Consumption Volume, Value and Growth Rate Forecast by Region (2022-2027)

15.2.1 Global Opioids Drug Consumption Volume and Growth Rate Forecast by Regions (2022-2027)

15.2.2 Global Opioids Drug Value and Growth Rate Forecast by Regions (2022-2027)

15.2.3 North America Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.4 East Asia Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.5 Europe Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.6 South Asia Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.7 Southeast Asia Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.8 Middle East Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.9 Africa Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.10 Oceania Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.2.11 South America Opioids Drug Consumption Volume, Revenue and Growth Rate Forecast (2022-2027)

15.3 Global Opioids Drug Consumption Volume, Revenue and Price Forecast by Type (2022-2027)

15.3.1 Global Opioids Drug Consumption Forecast by Type (2022-2027)

15.3.2 Global Opioids Drug Revenue Forecast by Type (2022-2027)

15.3.3 Global Opioids Drug Price Forecast by Type (2022-2027)

15.4 Global Opioids Drug Consumption Volume Forecast by Application (2022-2027)

15.5 Opioids Drug Market Forecast Under COVID-19

Chapter 16 Conclusions

Research Methodology